135 related articles for article (PubMed ID: 302660)
1. [Immunological abnormalities in epileptic children treated with anticonvulsivant drugs (author's transl)].
Blanco A; Palencia R; Blanco S; Solís P; Sánchez Villares E
An Esp Pediatr; 1977 May; 10(5):433-40. PubMed ID: 302660
[TBL] [Abstract][Full Text] [Related]
2. Immunological abnormalities and hydantoins.
Grob PJ; Herold GE
Br Med J; 1972 Jun; 2(5813):561-3. PubMed ID: 5032783
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of phenobarbital in controlling epilepsy in children.
Ismael S
Paediatr Indones; 1990; 30(3-4):97-110. PubMed ID: 2075011
[TBL] [Abstract][Full Text] [Related]
4. [Erythemic coelic lupus of a patient undergoing chronic treatment with hydantoinal (author's transl)].
Plamieniak Z; Bednorz W; Stepień M
Przegl Lek; 1975; 32(2):304-6. PubMed ID: 1078729
[No Abstract] [Full Text] [Related]
5. [Renal tubular acidification in patients treated with anticonvulsants (author's transl)].
González Macías J; Rodríguez Commes JL; de Manueles Jiménez J; Tabernero Romo JM; de Castro del Pozo S
Med Clin (Barc); 1980 Apr; 74(8):309-11. PubMed ID: 7374234
[TBL] [Abstract][Full Text] [Related]
6. [Disturbances of calcium-phosphate-metabolism by anticonvulsant drugs in relation to their serum concentration (author's transl)].
Stögmann W
Padiatr Padol; 1979; 14(1):89-95. PubMed ID: 105336
[TBL] [Abstract][Full Text] [Related]
7. [Modifications of phosphocalcic metabolism in patients treated with anticonvulsivants (author's transl)].
Palencia R; Blanco A; Blanco S
An Esp Pediatr; 1975; 8(6):626-9. PubMed ID: 1211691
[TBL] [Abstract][Full Text] [Related]
8. [Systemic lupus erythematosus induced by anticonvulsivant drug (author's transl)].
Tor J; Rey C; Fernández-Sevilla T; Martí Vilalta JL
Med Clin (Barc); 1979 Dec; 73(10):443-6. PubMed ID: 93671
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptics and the development of congenital anomalies.
Yerby MS; Leavitt A; Erickson DM; McCormick KB; Loewenson RB; Sells CJ; Benedetti TJ
Neurology; 1992 Apr; 42(4 Suppl 5):132-40. PubMed ID: 1574169
[TBL] [Abstract][Full Text] [Related]
10. Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients.
Verrotti A; Greco R; Altobelli E; Latini G; Morgese G; Chiarelli F
Clin Exp Med; 2003 May; 3(1):32-6. PubMed ID: 12748877
[TBL] [Abstract][Full Text] [Related]
11. [On the combination treatment of epileptic attacks].
Roth G
Wien Med Wochenschr; 1968 Feb; 118(6):116-8. PubMed ID: 4970152
[No Abstract] [Full Text] [Related]
12. Treatment with phenobarbital and monitoring of epileptic patients in rural Mali.
Nimaga K; Desplats D; Doumbo O; Farnarier G
Bull World Health Organ; 2002; 80(7):532-7. PubMed ID: 12163916
[TBL] [Abstract][Full Text] [Related]
13. [Follow-up examinations of epileptic children who interrupted treatment of their own volition].
Szelozyńska K; Dobrzyńska L
Neurol Neurochir Pol; 1971; 5(3):375-8. PubMed ID: 5116789
[No Abstract] [Full Text] [Related]
14. [The study of the hepatic clearance of 131I-rose-bengal in epileptic patients treated with phenobarbital associated or not with hydantoin (author's transl)].
Pirotte J
Acta Gastroenterol Belg; 1981; 44(7-8):328-35. PubMed ID: 6274119
[No Abstract] [Full Text] [Related]
15. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants.
Singsen BH; Fishman L; Hanson V
Pediatrics; 1976 Apr; 57(4):529-34. PubMed ID: 1083501
[TBL] [Abstract][Full Text] [Related]
16. [A neuro-immunological theory for some forms of epilepsy].
Gentile A; Caruso C; Puccini A; Celentano I
Acta Neurol Quad (Napoli); 1981; 42():3-10. PubMed ID: 7270067
[No Abstract] [Full Text] [Related]
17. [Megaloblastic anemia due to anticonvulsant therapy].
Mozziconacci P; Attai C; Pham-Huu-Trung ; Boisse J; Piussan C
Ann Pediatr (Paris); 1967; 14(6):466-70. PubMed ID: 5618046
[No Abstract] [Full Text] [Related]
18. [Malignant lymphoma following years of hydantoin treatment for epilepsy].
Jungi WF; Senn HJ; Stanisic M; Rösli R
Schweiz Med Wochenschr; 1975 Dec; 105(50):1735-7. PubMed ID: 1215968
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of phenobarbitone in epileptic children.
Singh LM; Mehta S; Vohra RM; Nain CK
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):18-22. PubMed ID: 3104216
[TBL] [Abstract][Full Text] [Related]
20. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
